Close

Pfizer (PFE) Announces Data Published in NEJM Shows its Tofacitinib Meets Primary Endpoint in Brazilian Study in Patients Hospitalized with COVID-19 Pneumonia

Go back to Pfizer (PFE) Announces Data Published in NEJM Shows its Tofacitinib Meets Primary Endpoint in Brazilian Study in Patients Hospitalized with COVID-19 Pneumonia
Pfizer Inc. (NYSE: PFE) Delayed: 26.25 -0.01 (0.04%)
Previous Close $26.26    52 Week High $37.39 
Open $26.33    52 Week Low $28.25 
Day High $26.47    P/E 15.91 
Day Low $26.19    EPS $1.65 
Volume 13,762,500